Literature DB >> 12115470

Immunogenicity of polymeric implants: long-term antibody response against polyester (Dacron) following the implantation of vascular prostheses into LEW.1A rats.

M Schlosser1, L Wilhelm, G Urban, B Ziegler, M Ziegler, R Zippel.   

Abstract

Implanted biomaterials trigger acute and chronic inflammatory responses directly correlated to the central role of phagocytic cells at the host-implant interface. This study was designed to evaluate specific humoral immune responses following repeated intraperitoneal implantations of collagen-impregnated polyester (Dacron) prosthetic segments into LEWIS rats. Serum antibody detection was performed by enzyme immunoassay with the prosthetic segments as a target. Cutoff values for antibody positivity were greater than or equal to the 99th percentile for control rats. Polymer immunoglobiulin G (IgG) antibodies were significantly increased (p < 0.05) by repeated implantation and were subsequently followed until experimental day 293. Antibody formation was significantly enhanced through the application of complete Freund's adjuvant in combination with the first implantation. All rats within this group were antibody-positive on day 53, but only 6 of 10 animals that received the prosthesis without the adjuvant were. After preincubation of sera with bovine collagen type I (solid phase adsorbed or in solution), polymer antibody binding was discovered not to be diminished, indicating that the IgG antibodies detected were not directed against the prosthesis impregnation. Furthermore, a significant correlation was obtained between polymer antibody binding to collagen-impregnated and nonimpregnated prostheses (r(s) = 0.797, p < 0.001). There was no substantiated correlation between antibody binding to polyester and to an irrelevant polymer (Tecoflex EG 80). We conclude that specific polymer antibodies may indeed provide an additional parameter for biocompatibility testing as well as a possible serological marker of an inflammatory response to implants. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115470     DOI: 10.1002/jbm.10096

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  6 in total

1.  Evaluation of the biocompatibility of a new vascular prosthesis coating by detection of prosthesis-specific antibodies.

Authors:  Uwe Walschus; Helmut Goldmann; Torsten Ueberrueck; Andreas Hoene; Lutz Wilhelm; Michael Schlosser
Journal:  J Mater Sci Mater Med       Date:  2007-11-29       Impact factor: 3.896

2.  Delayed reaction to the Dacron buttress used in Stamey bladder neck suspension.

Authors:  Alkiviadis Gregorakis; Constantine Bouropoulos; Demitrios Dimitriou; George Rallis; Spyros Vernadakis; Iordanis N Papadopoulos; Ioannis Kastriotis
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 3.  Microencapsulation-based cell therapies.

Authors:  Safiya Naina Marikar; Assam El-Osta; Angus Johnston; Georgina Such; Keith Al-Hasani
Journal:  Cell Mol Life Sci       Date:  2022-06-08       Impact factor: 9.207

4.  In vivo examination of the local inflammatory response after implantation of Ti6Al4V samples with a combined low-temperature plasma treatment using pulsed magnetron sputtering of copper and plasma-polymerized ethylenediamine.

Authors:  Andreas Hoene; Maciej Patrzyk; Uwe Walschus; Vítězslav Straňák; Rainer Hippler; Holger Testrich; Jürgen Meichsner; Birgit Finke; Henrike Rebl; Barbara Nebe; Carmen Zietz; Rainer Bader; Andreas Podbielski; Michael Schlosser
Journal:  J Mater Sci Mater Med       Date:  2013-01-12       Impact factor: 3.896

5.  International guidelines for groin hernia management.

Authors: 
Journal:  Hernia       Date:  2018-01-12       Impact factor: 4.739

6.  Biohybrid elastin-like venous valve with potential for in situ tissue engineering.

Authors:  Fernando González-Pérez; Sergio Acosta; Stephan Rütten; Caroline Emonts; Alexander Kopp; Heinz-Werner Henke; Philipp Bruners; Thomas Gries; J Carlos Rodríguez-Cabello; Stefan Jockenhoevel; Alicia Fernández-Colino
Journal:  Front Bioeng Biotechnol       Date:  2022-09-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.